• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T 细胞受体切除环水平与儿科免疫接种的安全性:基于人群的自身对照病例系列分析。

T-cell receptor excision circle levels and safety of paediatric immunization: A population-based self-controlled case series analysis.

机构信息

a Clinical Epidemiology Program, Ottawa Hospital Research Institute , Ottawa , Canada.

b School of Epidemiology and Public Health, University of Ottawa , Ottawa , Canada.

出版信息

Hum Vaccin Immunother. 2018 Jun 3;14(6):1378-1391. doi: 10.1080/21645515.2018.1433971. Epub 2018 Feb 26.

DOI:10.1080/21645515.2018.1433971
PMID:29420131
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6037463/
Abstract

T-cell receptor excision circle levels are a surrogate marker of T-cell production and immune system function. We sought to determine whether non-pathological levels of infant T-cell receptor excision circles were associated with adverse events following immunization. A self-controlled case series design was applied on a sample of 231,693 children who completed newborn screening for severe combined immunodeficiency in Ontario, Canada between August 2013 and December 2015. Exposures included routinely administered pediatric vaccines up to 15 months of age. Main outcomes were combined health services utilization for recognized adverse events following immunization. 1,406,981 vaccination events were included in the final dataset. 103,007 children received the Pneu-C-13 or Men-C-C vaccine and 97,998 received the MMR vaccine at 12 months of age. 67,725 children received the varicella immunization at 15 months. Our analysis identified no association between newborn T-cell receptor excision circle levels and subsequent health services utilization events following DTa-IPV-Hib, Pneu-C-13, and Men-C-C vaccinations at 2-month (RI 0.94[95%CI 0.87-1.02]), 4-month (RI 0.82[95%CI 0.75-0.9]), 6-month (RI 0.63[95%CI 0.57-0.7]) and 12-month (RI 0.49[95%CI 0.44-0.55]). We also found no trends in health services utilization following MMR (RI 1.43[95%1.34-1.52]) or varicella (RI 1.14[95%CI 1.05-1.23]) vaccination. Our findings provide further support for the safety of pediatric vaccinations.

摘要

T 细胞受体切除环水平是 T 细胞产生和免疫系统功能的替代标志物。我们旨在确定婴儿 T 细胞受体切除环的非病理性水平是否与免疫接种后的不良事件有关。在加拿大安大略省,2013 年 8 月至 2015 年 12 月期间,对 231693 名接受严重联合免疫缺陷新生儿筛查的儿童进行了一项自我对照病例系列设计。暴露包括在 15 个月龄之前常规给予儿科疫苗。主要结局是识别出的免疫接种后不良事件的综合卫生服务利用。最终数据集包括 1406981 次疫苗接种事件。103007 名儿童在 12 个月龄时接种了 Pneu-C-13 或 Men-C-C 疫苗,97998 名儿童在 12 个月龄时接种了 MMR 疫苗,67725 名儿童在 15 个月龄时接种了水痘疫苗。我们的分析没有发现新生儿 T 细胞受体切除环水平与 DTa-IPV-Hib、Pneu-C-13 和 Men-C-C 疫苗接种后 2 个月(RI 0.94[95%CI 0.87-1.02])、4 个月(RI 0.82[95%CI 0.75-0.9])、6 个月(RI 0.63[95%CI 0.57-0.7])和 12 个月(RI 0.49[95%CI 0.44-0.55])的后续卫生服务利用事件之间存在关联。我们还发现 MMR(RI 1.43[95%1.34-1.52])或水痘(RI 1.14[95%CI 1.05-1.23])疫苗接种后卫生服务利用也没有趋势。我们的研究结果为儿科疫苗接种的安全性提供了进一步的支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/6037463/8bc38f5abc07/khvi-14-06-1433971-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/6037463/ab236c4274ed/khvi-14-06-1433971-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/6037463/97d2330a4fe5/khvi-14-06-1433971-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/6037463/caebab36f6e3/khvi-14-06-1433971-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/6037463/8bc38f5abc07/khvi-14-06-1433971-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/6037463/ab236c4274ed/khvi-14-06-1433971-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/6037463/97d2330a4fe5/khvi-14-06-1433971-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/6037463/caebab36f6e3/khvi-14-06-1433971-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d7/6037463/8bc38f5abc07/khvi-14-06-1433971-g004.jpg

相似文献

1
T-cell receptor excision circle levels and safety of paediatric immunization: A population-based self-controlled case series analysis.T 细胞受体切除环水平与儿科免疫接种的安全性:基于人群的自身对照病例系列分析。
Hum Vaccin Immunother. 2018 Jun 3;14(6):1378-1391. doi: 10.1080/21645515.2018.1433971. Epub 2018 Feb 26.
2
Seasonal variation in rates of emergency room visits and acute admissions following recommended infant vaccinations in Ontario, Canada: a self-controlled case series analysis.加拿大安大略省婴儿接种推荐疫苗后急诊就诊率和急性住院率的季节性变化:一项自我对照病例系列分析
Vaccine. 2014 Dec 12;32(52):7148-53. doi: 10.1016/j.vaccine.2014.09.059. Epub 2014 Nov 1.
3
Association between socioeconomic status and adverse events following immunization at 2, 4, 6 and 12 months.社会经济地位与 2、4、6 和 12 个月时免疫接种后不良事件的关系。
Hum Vaccin Immunother. 2013 May;9(5):1153-7. doi: 10.4161/hv.23533. Epub 2013 Jan 17.
4
Incidence of adverse events in premature children following 2-month vaccination.早产儿接种疫苗后 2 个月内不良事件的发生率。
Hum Vaccin Immunother. 2012 May;8(5):592-5. doi: 10.4161/hv.19377. Epub 2012 May 1.
5
Post-licensure rapid immunization safety monitoring program (PRISM) data characterization.疫苗上市后快速免疫安全性监测项目(PRISM)数据特征描述。
Vaccine. 2013 Dec 30;31 Suppl 10:K98-112. doi: 10.1016/j.vaccine.2013.04.088.
6
Safety of routine childhood vaccine coadministration versus separate vaccination.常规儿童疫苗同时接种与分开接种的安全性。
BMJ Glob Health. 2022 Sep;7(9). doi: 10.1136/bmjgh-2021-008215.
7
Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.为全球引入灭活脊髓灰质炎病毒疫苗做准备:来自美国疫苗不良事件报告系统的安全性证据,2000-2012 年。
Lancet Infect Dis. 2015 Oct;15(10):1175-1182. doi: 10.1016/S1473-3099(15)00059-6. Epub 2015 Aug 16.
8
Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.四价脑膜炎球菌血清群 A、C、W 和 Y 结合疫苗(MenACWY-CRM)与常规婴儿疫苗联合接种的安全性:一项在健康婴儿中进行的开放性、随机、3b 期对照研究结果。
Vaccine. 2014 Feb 12;32(8):965-72. doi: 10.1016/j.vaccine.2013.12.034. Epub 2014 Jan 4.
9
Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.七价肺炎球菌结合疫苗(PCV7)与全液体百白破-灭活脊髓灰质炎病毒-乙肝-流感嗜血杆菌结合疫苗同时接种于健康婴儿的免疫原性、反应原性及安全性。
Vaccine. 2008 Jun 13;26(25):3142-52. doi: 10.1016/j.vaccine.2007.11.096. Epub 2008 May 6.
10
Vaccine-related adverse events in Cuban children, 1999-2008.1999-2008 年古巴儿童的疫苗相关不良事件。
MEDICC Rev. 2012 Jan;14(1):38-43. doi: 10.37757/MR2012V14.N1.8.

引用本文的文献

1
IN TIME: THE VALUE AND GLOBAL IMPLICATIONSOF NEWBORN SCREENING FORSEVERE COMBINED IMMUNODEFICIENCY.及时:新生儿重症联合免疫缺陷筛查的价值及全球影响
Rev Paul Pediatr. 2018 Oct-Dec;36(4):388-397. doi: 10.1590/1984-0462/;2018;36;4;00020.
2
Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation.造血干细胞移植前后的胸腺生成。
Front Immunol. 2018 Sep 7;9:1889. doi: 10.3389/fimmu.2018.01889. eCollection 2018.

本文引用的文献

1
Newborn Screening for Severe Combined Immunodeficiency in the US: Current Status and Approach to Management.美国严重联合免疫缺陷病的新生儿筛查:现状与管理方法
Int J Neonatal Screen. 2017 Jun;3(2). doi: 10.3390/ijns3020015. Epub 2017 Jun 21.
2
Metabolites as biomarkers of adverse reactions following vaccination: A pilot study using nuclear magnetic resonance metabolomics.代谢物作为疫苗接种后不良反应的生物标志物:一项使用核磁共振代谢组学的初步研究。
Vaccine. 2017 Mar 1;35(9):1238-1245. doi: 10.1016/j.vaccine.2017.01.056. Epub 2017 Feb 3.
3
Vaccination in Primary Immunodeficiency Disorders.
原发性免疫缺陷病的疫苗接种。
J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1066-1075. doi: 10.1016/j.jaip.2016.09.012.
4
The use of relative incidence ratios in self-controlled case series studies: an overview.自我对照病例系列研究中相对发病率比的应用:综述
BMC Med Res Methodol. 2016 Sep 23;16(1):126. doi: 10.1186/s12874-016-0225-0.
5
Adverse events following immunization in patients with primary immunodeficiencies.原发性免疫缺陷患者免疫接种后的不良事件。
Vaccine. 2016 Mar 18;34(13):1611-1616. doi: 10.1016/j.vaccine.2016.01.047. Epub 2016 Feb 2.
6
Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities.原发性免疫缺陷、继发性免疫缺陷以及伴有免疫调节异常的自身免疫患者的疫苗接种。
Immunotherapy. 2015;7(12):1273-92. doi: 10.2217/IMT.15.74. Epub 2015 Aug 20.
7
Validation of infant immunization billing codes in administrative data.行政数据中婴儿免疫接种计费代码的验证
Hum Vaccin Immunother. 2015;11(7):1840-7. doi: 10.1080/21645515.2015.1043499.
8
Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.美国11个筛查项目中对重症联合免疫缺陷的新生儿筛查。
JAMA. 2014 Aug 20;312(7):729-38. doi: 10.1001/jama.2014.9132.
9
Safety of vaccines used for routine immunization of U.S. children: a systematic review.美国儿童常规免疫所用疫苗的安全性:一项系统评价
Pediatrics. 2014 Aug;134(2):325-37. doi: 10.1542/peds.2014-1079. Epub 2014 Jul 1.
10
Vaccine-associated varicella and rubella infections in severe combined immunodeficiency with isolated CD4 lymphocytopenia and mutations in IL7R detected by tandem whole exome sequencing and chromosomal microarray.通过串联全外显子组测序和染色体微阵列检测到的伴有孤立性CD4淋巴细胞减少和IL7R基因突变的重症联合免疫缺陷患者中与疫苗相关的水痘和风疹感染
Clin Exp Immunol. 2014 Dec;178(3):459-69. doi: 10.1111/cei.12421.